Apcotex Industries (APCOTEXIND) Q2 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 26/27 earnings summary
29 Oct, 2026Executive summary
H1 FY27 delivered record EBITDA, PBT and PAT, supported by higher volumes and improved margins.
Q2 revenue rose 48.2% YoY to ₹49,892.46 lakh; sales volume grew 7% YoY, with exports recovering from Q1.
Financial highlights
Q2 EBITDA was INR 583m, up 43.6% YoY; net profit was ₹3,483.65 lakh, up 37.5%.
H1 revenue rose 43.8% to ₹1,02,455.81 lakh; EBITDA increased 121.2% to INR 1,754m and net profit rose 155.7% to ₹11,377.58 lakh.
H1 diluted EPS increased 156.1% to INR 21.95; total comprehensive income rose 140.9% to ₹12,070.38 lakh.
Outlook and guidance
Overall business volume growth expected at ~10% annually over the next 3–5 years, averaging 20%–30% above GDP growth.
Valia NBR expansion targets commissioning in April 2027, with utilization expected to ramp over 2–3 years; SBR latex plant is expected to start in Q2 of the next financial year.
Nitrile latex expansion decision deferred pending several more quarters of consistent margins; current margins have improved from the prior three years.
October–November oil price increases may enable partial recovery of prior pricing and inventory pressures; quarter outcome remains subject to conditions ahead.
Latest events from Apcotex Industries
- Sales grew, but import-driven price pressure left a Rs 296.28 lacs net loss.APCOTEXIND
Q4 00/01 - Sales growth and new products drove a return to profit amid persistent competitive pressure.APCOTEXIND
Q4 01/02 - Sales grew 24.9%, but input-cost pressure sharply eroded profit.APCOTEXIND
Q4 03/04 - Sales advanced, but high petrochemical costs kept margins under pressure.APCOTEXIND
Q4 04/05 - Sales surged, but import competition squeezed margins and operating cash flow stayed negative.APCOTEXIND
Q4 99/00 - Sales and profits surged as the merger completed and export growth opportunities expanded.APCOTEXIND
Q4 17/18 - Sales and profit rebounded sharply, but rising input costs threaten margins.APCOTEXIND
Q4 07/08 - Sales and exports surged, but input volatility and FX exposure clouded the outlook.APCOTEXIND
Q4 11/12 - Sales rose 20%, profit increased, and capacity expansion moved ahead.APCOTEXIND
Q4 96/97